nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—SLC12A1—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.0124	0.0124	CbGpPWpGaD
Torasemide—CYP2C19—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.012	0.012	CbGpPWpGaD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.012	0.012	CbGpPWpGaD
Torasemide—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.012	0.012	CbGpPWpGaD
Torasemide—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.0114	0.0114	CbGpPWpGaD
Torasemide—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.011	0.011	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0108	0.0108	CbGpPWpGaD
Torasemide—CYP2C19—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.0102	0.0102	CbGpPWpGaD
Torasemide—SLC12A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00884	0.00884	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00799	0.00799	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00799	0.00799	CbGpPWpGaD
Torasemide—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00765	0.00765	CbGpPWpGaD
Torasemide—PTGS1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00757	0.00757	CbGpPWpGaD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00747	0.00747	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00731	0.00731	CbGpPWpGaD
Torasemide—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00713	0.00713	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00695	0.00695	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00685	0.00685	CbGpPWpGaD
Torasemide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00671	0.00671	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—TNF—Parkinson's disease	0.00652	0.00652	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTA4—Parkinson's disease	0.00641	0.00641	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00637	0.00637	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00631	0.00631	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00628	0.00628	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0062	0.0062	CbGpPWpGaD
Torasemide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00612	0.00612	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00601	0.00601	CbGpPWpGaD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00583	0.00583	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00582	0.00582	CbGpPWpGaD
Torasemide—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.0058	0.0058	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00575	0.00575	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—MAOB—Parkinson's disease	0.00571	0.00571	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00568	0.00568	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00565	0.00565	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00561	0.00561	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00561	0.00561	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—IL6—Parkinson's disease	0.00527	0.00527	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0052	0.0052	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00518	0.00518	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00516	0.00516	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00513	0.00513	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00511	0.00511	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00505	0.00505	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00489	0.00489	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00482	0.00482	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00474	0.00474	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00472	0.00472	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00468	0.00468	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00461	0.00461	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00449	0.00449	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00444	0.00444	CbGpPWpGaD
Torasemide—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00436	0.00436	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00432	0.00432	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP2D6—Parkinson's disease	0.00424	0.00424	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00421	0.00421	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.0042	0.0042	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTA4—Parkinson's disease	0.00414	0.00414	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00408	0.00408	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00398	0.00398	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00388	0.00388	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP2E1—Parkinson's disease	0.00388	0.00388	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00384	0.00384	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00375	0.00375	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00369	0.00369	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—MAOB—Parkinson's disease	0.00369	0.00369	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00364	0.00364	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.0036	0.0036	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00355	0.00355	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—INS—Parkinson's disease	0.00354	0.00354	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00347	0.00347	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.00337	0.00337	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00332	0.00332	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.00329	0.00329	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—COMT—Parkinson's disease	0.00322	0.00322	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTP1—Parkinson's disease	0.0032	0.0032	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—MAOA—Parkinson's disease	0.00319	0.00319	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00316	0.00316	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.003	0.003	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTM1—Parkinson's disease	0.00294	0.00294	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.00274	0.00274	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.0027	0.0027	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00264	0.00264	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.00251	0.00251	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00247	0.00247	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.00245	0.00245	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00241	0.00241	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00229	0.00229	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.00224	0.00224	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.00223	0.00223	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00222	0.00222	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00221	0.00221	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.0022	0.0022	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.00209	0.00209	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ND3—Parkinson's disease	0.00209	0.00209	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.00208	0.00208	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.00207	0.00207	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.00206	0.00206	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.00205	0.00205	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00205	0.00205	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00204	0.00204	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00204	0.00204	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00201	0.00201	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—OMD—Parkinson's disease	0.00196	0.00196	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.00196	0.00196	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00187	0.00187	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00187	0.00187	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.00186	0.00186	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.00183	0.00183	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00182	0.00182	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GCH1—Parkinson's disease	0.00177	0.00177	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.00168	0.00168	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.00168	0.00168	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00166	0.00166	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—FBP1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—DBH—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GBA—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.00155	0.00155	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ND3—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00128	0.00128	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—OMD—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ND3—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—DDC—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—OMD—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ND3—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—OMD—Parkinson's disease	0.00103	0.00103	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—DBH—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GBA—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000987	0.000987	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000978	0.000978	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000977	0.000977	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000933	0.000933	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00093	0.00093	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000922	0.000922	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000912	0.000912	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000912	0.000912	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000912	0.000912	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000841	0.000841	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000831	0.000831	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000831	0.000831	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000831	0.000831	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—DDC—Parkinson's disease	0.00075	0.00075	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000726	0.000726	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000713	0.000713	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.000708	0.000708	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000699	0.000699	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000669	0.000669	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000664	0.000664	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000657	0.000657	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—TH—Parkinson's disease	0.000647	0.000647	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000637	0.000637	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000632	0.000632	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000631	0.000631	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000624	0.000624	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000621	0.000621	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—DDC—Parkinson's disease	0.00061	0.00061	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.0006	0.0006	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000576	0.000576	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000569	0.000569	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000569	0.000569	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000563	0.000563	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—COMT—Parkinson's disease	0.00055	0.00055	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000546	0.000546	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.00054	0.00054	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000536	0.000536	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000519	0.000519	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000518	0.000518	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000513	0.000513	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000503	0.000503	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000489	0.000489	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000482	0.000482	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000469	0.000469	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.00046	0.00046	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000445	0.000445	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	0.000429	0.000429	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NQO1—Parkinson's disease	0.000424	0.000424	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000419	0.000419	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TH—Parkinson's disease	0.000418	0.000418	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—APOE—Parkinson's disease	0.000414	0.000414	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.000411	0.000411	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYCS—Parkinson's disease	0.000401	0.000401	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000383	0.000383	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000382	0.000382	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000379	0.000379	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000375	0.000375	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TH—Parkinson's disease	0.000373	0.000373	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000358	0.000358	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—COMT—Parkinson's disease	0.000355	0.000355	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTP1—Parkinson's disease	0.000354	0.000354	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—INS—Parkinson's disease	0.000354	0.000354	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MAOA—Parkinson's disease	0.000353	0.000353	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000349	0.000349	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—HMOX1—Parkinson's disease	0.000349	0.000349	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000345	0.000345	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TH—Parkinson's disease	0.00034	0.00034	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ABCB1—Parkinson's disease	0.000335	0.000335	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000327	0.000327	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTM1—Parkinson's disease	0.000325	0.000325	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000317	0.000317	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000316	0.000316	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.000315	0.000315	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000311	0.000311	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GPX1—Parkinson's disease	0.000311	0.000311	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000299	0.000299	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.00029	0.00029	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000289	0.000289	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000288	0.000288	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MTHFR—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000284	0.000284	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000278	0.000278	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000272	0.000272	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—APOE—Parkinson's disease	0.000267	0.000267	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.000265	0.000265	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MTHFR—Parkinson's disease	0.000256	0.000256	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GPX1—Parkinson's disease	0.000253	0.000253	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—APOE—Parkinson's disease	0.000239	0.000239	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	0.000234	0.000234	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—INS—Parkinson's disease	0.000228	0.000228	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—APOE—Parkinson's disease	0.000218	0.000218	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—INS—Parkinson's disease	0.000204	0.000204	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—INS—Parkinson's disease	0.000186	0.000186	CbGpPWpGaD
